Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.
The European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, calling for action to prevent antimicrobial resistance from undermining ...
Reversing an earlier decision, European regulators recommended that the Alzheimer’s therapy Leqembi should be approved ...
Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...
(RTTNews) - Janssen-Cilag International NV, a Johnson & Johnson company (JNJ), Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has ...
The study showed significant reductions in serum TTR levels in subjects after a single dose, with sustained effects over time ...
Lilly said it has already started submitting the SUMMIT data to the FDA and European Medicines Agency regulators for ...
3d
Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced a positive opinion has been received from the Committee for Medicinal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback